Amoy Diagnostics Co., Ltd.
Symbol: 300685.SZ
SHZ
20.6
CNYTržní cena dnes
34.8241
Poměr P/E
0.0000
Poměr PEG
8.13B
MRK Cap
- 0.01%
Výnos DIV
Amoy Diagnostics Co., Ltd. (300685-SZ) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0 | 754 | 718.7 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 259.3 | 315.9 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 478.8 | 437.6 | ||||||||||||
balance-sheet.row.inventory | 0 | 0 | 32.8 | 32.3 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 19.5 | 7.4 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 0 | 1285.1 | 1196 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 208.3 | 209.5 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 47.2 | 19.1 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 47.2 | 19.1 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | -200.7 | -248.2 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 6.5 | 20.5 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 304.5 | 323.1 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 0 | 365.8 | 323.9 | ||||||||||||
balance-sheet.row.other-assets | 0 | 1946.5 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 1946.5 | 1650.9 | 1519.9 | ||||||||||||
balance-sheet.row.account-payables | 0 | 0 | 21.3 | 24 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 5.3 | 3.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 8.8 | 17.1 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 48.3 | 3 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 10.3 | 11.2 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 0 | 0.6 | 0.1 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 0 | 59.2 | 15 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 1.7 | 3 | ||||||||||||
balance-sheet.row.total-liab | 0 | 0 | 151.2 | 150.3 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 398.6 | 398.2 | 221.7 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 0 | 827.7 | 637.2 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 3.5 | 91.6 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1302.5 | 270.4 | 414.1 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1701.1 | 1499.7 | 1364.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 0 | 1650.9 | 1519.9 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 5.1 | ||||||||||||
balance-sheet.row.total-equity | 0 | 1701.1 | 1499.7 | 1369.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 0 | 58.6 | 67.6 | ||||||||||||
balance-sheet.row.total-debt | 0 | 0 | 53.6 | 6.1 | ||||||||||||
balance-sheet.row.net-debt | 0 | 0 | -441 | -396.8 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 256.3 | 264.3 | 239 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 52.3 | 38.9 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 13.7 | -1.1 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | -13.7 | 1.1 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | 0 | -58.9 | -125.1 | ||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 25.9 | -132.3 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | -0.6 | -10.8 | ||||||||||||
cash-flows.row.account-payables | 0 | 0 | -98 | 19.2 | ||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 13.7 | -1.1 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | -256.3 | -108.6 | 15.4 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -78.3 | -74.5 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 51.9 | 8.9 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -363.6 | -772.1 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 350.2 | 600.7 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -0.5 | -5.6 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -40.2 | -242.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -1.1 | 0 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 100.7 | 0 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -100.7 | -4.4 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -51.5 | -55.4 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | -68 | 13.5 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | -120.6 | -46.3 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 24.6 | -10 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | 0 | 12.9 | -130.8 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 244 | 243.6 | 230.7 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 244 | 230.7 | 361.6 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 0 | 149 | 168.2 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -78.3 | -74.5 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | 0 | 70.8 | 93.6 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1043.6 | 842.2 | 917 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 147.8 | 143.3 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 1043.6 | 694.4 | 773.8 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | -748.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 748.4 | 524.3 | 508.9 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 748.4 | 672.1 | 652.2 | ||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 6.1 | 3.1 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 1 | 0.4 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -6.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -748.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -6.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 1 | 0.4 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | -32.5 | 52.3 | 38.9 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 295.1 | 287.7 | 253.2 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 288.7 | 286.1 | 252 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 32.5 | 21.8 | 13 | ||||||||||||
income-statement-row.row.net-income | 0 | 256.3 | 263.7 | 239.6 |
Často kladené otázky
Co je Amoy Diagnostics Co., Ltd. (300685.SZ) celková aktiva?
Amoy Diagnostics Co., Ltd. (300685.SZ) celková aktiva jsou 1946538300.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.889.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je 0.444.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 0.246.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou 0.283.
Co je Amoy Diagnostics Co., Ltd. (300685.SZ) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je 256255700.000.
Jaký je celkový dluh podniku?
Celkový dluh je 0.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 748437800.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.